Christopher W. Fulton

Array ( [id] => 1231925 [patent_doc_number] => 06693167 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-17 [patent_title] => 'Peptide-based gemini compounds' [patent_app_type] => B1 [patent_app_number] => 09/581068 [patent_app_country] => US [patent_app_date] => 2000-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8683 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/693/06693167.pdf [firstpage_image] =>[orig_patent_app_number] => 09581068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1418279 [patent_doc_number] => 06512093 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-28 [patent_title] => 'Method of preparing lipoproteins from fatty acids present in olive oil' [patent_app_type] => B1 [patent_app_number] => 09/555867 [patent_app_country] => US [patent_app_date] => 2000-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1673 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/512/06512093.pdf [firstpage_image] =>[orig_patent_app_number] => 09555867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1517504 [patent_doc_number] => 06500803 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Factor VIIa inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/588651 [patent_app_country] => US [patent_app_date] => 2000-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23501 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1289 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500803.pdf [firstpage_image] =>[orig_patent_app_number] => 09588651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342297 [patent_doc_number] => 06590081 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-08 [patent_title] => 'Crystalline teriparatide' [patent_app_type] => B1 [patent_app_number] => 09/555447 [patent_app_country] => US [patent_app_date] => 2000-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3778 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/590/06590081.pdf [firstpage_image] =>[orig_patent_app_number] => 09555447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1265554 [patent_doc_number] => 06660836 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-09 [patent_title] => 'Methods for carbon-centered radical mediated heavy hydrogen labeling of compounds' [patent_app_type] => B1 [patent_app_number] => 09/579112 [patent_app_country] => US [patent_app_date] => 2000-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 36603 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/660/06660836.pdf [firstpage_image] =>[orig_patent_app_number] => 09579112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 620178 [patent_doc_number] => 07141593 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-11-28 [patent_title] => 'Pharmaceutical formulations' [patent_app_type] => utility [patent_app_number] => 09/576097 [patent_app_country] => US [patent_app_date] => 2000-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8914 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/141/07141593.pdf [firstpage_image] =>[orig_patent_app_number] => 09576097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 577562 [patent_doc_number] => 07456150 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-11-25 [patent_title] => 'Pulmonary delivery of active fragments of parathyroid hormone' [patent_app_type] => utility [patent_app_number] => 09/577264 [patent_app_country] => US [patent_app_date] => 2000-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3911 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/456/07456150.pdf [firstpage_image] =>[orig_patent_app_number] => 09577264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1395737 [patent_doc_number] => 06545125 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Compounds with antitumor activity' [patent_app_type] => B1 [patent_app_number] => 09/554706 [patent_app_country] => US [patent_app_date] => 2000-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2980 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/545/06545125.pdf [firstpage_image] =>[orig_patent_app_number] => 09554706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1596068 [patent_doc_number] => 06384187 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Antiproliferative activity of microsclerodermins' [patent_app_type] => B1 [patent_app_number] => 09/568692 [patent_app_country] => US [patent_app_date] => 2000-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4073 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/384/06384187.pdf [firstpage_image] =>[orig_patent_app_number] => 09568692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1290325 [patent_doc_number] => 06632922 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => 'Methods and compositions for controlled polypeptide synthesis' [patent_app_type] => B1 [patent_app_number] => 09/568121 [patent_app_country] => US [patent_app_date] => 2000-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 31849 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632922.pdf [firstpage_image] =>[orig_patent_app_number] => 09568121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1176835 [patent_doc_number] => 06747127 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-08 [patent_title] => 'Substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulators' [patent_app_type] => B1 [patent_app_number] => 09/565715 [patent_app_country] => US [patent_app_date] => 2000-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7939 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/747/06747127.pdf [firstpage_image] =>[orig_patent_app_number] => 09565715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1262176 [patent_doc_number] => 06664368 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'Inhibition of nuclear import by backbone cyclic peptide analogs' [patent_app_type] => B1 [patent_app_number] => 09/564677 [patent_app_country] => US [patent_app_date] => 2000-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 7637 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664368.pdf [firstpage_image] =>[orig_patent_app_number] => 09564677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1156453 [patent_doc_number] => 06765019 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-20 [patent_title] => 'Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids' [patent_app_type] => B1 [patent_app_number] => 09/565079 [patent_app_country] => US [patent_app_date] => 2000-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 9430 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 281 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/765/06765019.pdf [firstpage_image] =>[orig_patent_app_number] => 09565079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 935451 [patent_doc_number] => 06974800 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-12-13 [patent_title] => 'Formulations comprising an inhibitor of carboxypeptidase U and A thrombin inhibitor' [patent_app_type] => utility [patent_app_number] => 09/600659 [patent_app_country] => US [patent_app_date] => 2000-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10228 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/974/06974800.pdf [firstpage_image] =>[orig_patent_app_number] => 09600659 [rel_patent_id] =>[rel_patent_doc_number] =>)